AKIMOV, A.; CHERNIAVSKYI , V. Comparative effects of liraglutide and dapagliflozin on lipid profile and cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes: a 6-month randomized study. The Ukrainian Scientific Medical Youth Journal, v. 158, n. 4, p. 17-26, 22 Dec. 2025.